TD Asset Management Inc Sells 3,600 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

Key Points

• TD Asset Management Inc has reduced its stock position in Prestige Consumer Healthcare Inc. by 11.4%, owning 28,000 shares valued at approximately $2.41 million.
• Several institutional investors have increased their stakes in Prestige Consumer Healthcare, with CIBC Private Wealth Group raising its position by nearly 49% in the last quarter.
• Prestige Consumer Healthcare reported a quarterly earnings per share of $1.32, exceeding expectations and showing a 7% revenue increase year-over-year, with projected earnings for the current fiscal year at 4.5 EPS.

TD Asset Management Inc cut its stake in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 11.4% in the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 28,000 shares of the company's stock after selling 3,600 shares during the period. TD Asset Management Inc owned about 0.06% of Prestige Consumer Healthcare worth $2,407,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Cerity Partners LLC raised its stake in shares of Prestige Consumer Healthcare by 3.7% during the first quarter. Cerity Partners LLC now owns 3,666 shares of the company's stock valued at $315,000 after acquiring an additional 132 shares during the last quarter. Franklin Resources Inc. increased its stake in shares of Prestige Consumer Healthcare by 0.7% during the fourth quarter. Franklin Resources Inc. now owns 21,735 shares of the company's stock valued at $1,697,000 after purchasing an additional 150 shares in the last quarter. KBC Group NV increased its stake in shares of Prestige Consumer Healthcare by 7.4% during the first quarter. KBC Group NV now owns 2,199 shares of the company's stock valued at $189,000 after purchasing an additional 151 shares in the last quarter. CIBC Private Wealth Group LLC increased its stake in shares of Prestige Consumer Healthcare by 48.9% during the fourth quarter. CIBC Private Wealth Group LLC now owns 463 shares of the company's stock valued at $34,000 after purchasing an additional 152 shares in the last quarter. Finally, McIlrath & Eck LLC grew its holdings in shares of Prestige Consumer Healthcare by 19.1% during the fourth quarter. McIlrath & Eck LLC now owns 959 shares of the company's stock valued at $75,000 after buying an additional 154 shares during the last quarter. 99.95% of the stock is currently owned by hedge funds and other institutional investors.

Prestige Consumer Healthcare Stock Performance

PBH traded up $0.37 during trading on Wednesday, hitting $74.41. The company's stock had a trading volume of 107,377 shares, compared to its average volume of 365,833. The company has a quick ratio of 2.82, a current ratio of 4.20 and a debt-to-equity ratio of 0.55. Prestige Consumer Healthcare Inc. has a one year low of $64.94 and a one year high of $90.04. The firm has a market cap of $3.68 billion, a PE ratio of 17.32, a P/E/G ratio of 2.23 and a beta of 0.43. The business's 50 day simple moving average is $80.18 and its 200-day simple moving average is $82.24.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The company reported $1.32 earnings per share for the quarter, topping the consensus estimate of $1.30 by $0.02. Prestige Consumer Healthcare had a net margin of 18.86% and a return on equity of 12.87%. The business had revenue of $296.52 million for the quarter, compared to the consensus estimate of $289.36 million. During the same period last year, the firm earned $1.02 earnings per share. The company's quarterly revenue was up 7.0% on a year-over-year basis. As a group, sell-side analysts predict that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

Analysts Set New Price Targets

PBH has been the topic of a number of recent analyst reports. Royal Bank Of Canada upgraded shares of Prestige Consumer Healthcare to a "hold" rating in a report on Thursday, May 8th. Wall Street Zen upgraded shares of Prestige Consumer Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, July 5th. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, Prestige Consumer Healthcare presently has a consensus rating of "Moderate Buy" and an average target price of $93.33.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.